At least 1 major cardiovascular risk factor, including: high risk for ASCVD (individuals who meet criteria for Lipid-Lowering Therapy (LLT) based on ASCVD risk assessment using the most up-to-date guidelines), known ASCVD or subclinical ASCVD based on imaging, clinically diagnosed familial hypercholesterolemia or LDL-C ≥190 mg/dL, diabetes mellitus, history of statin-associated side effects
Has a primary care physician and/or cardiologist who can prescribe lipid therapy
Owns a smartphone and agrees to the End User License Agreement to use the digital health app
Provided informed consent before initiation of study-specific activities
You may not be if
Motor, cognitive, auditory, or visual impairment limiting technology use
Does not speak English
Malignancy (except nonmelanoma skin cancers or cervical or breast ductal carcinoma in situ within the previous 5 years)
Pregnancy (positive pregnancy test, highly sensitive urine or serum), plan to become pregnant or donate eggs, breastfeeding or plan to breastfeed
Likely to not be available to comply with all required study procedures to the best of the patient's and investigator's knowledge
History or evidence of any other clinically significant disorder, condition, or disease that, in the opinion of the investigator, would pose a risk to patient safety or interfere with the study evaluation, procedures, or completion
